New biomarker can predict MS severity

It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using...

Working to stop MS in its tracks

Working to stop MS in its tracks: On World Brain Day (22 July), work continues to diagnose multiple sclerosis (MS) earlier, provide access to life-changing...

Aluminium in human brain tissue

We have now measured the concentration of aluminium in human brain tissue from over two hundred donors involving at least five different brain banks. This...

Q&A with Professor Scott Byrne

Professor Scott Byrne, based at the University of Sydney in Australia, is one of a team of researchers around the world looking into how sunlight...

A role for aluminium in multiple sclerosis

Multiple sclerosis (MS) is a devastating disease of the central nervous system and affects approximately 100,000 individuals in the United Kingdom. The cause of MS...

Brain shrinkage in multiple sclerosis

Multiple sclerosis (MS) affects around 100,000 people in the UK. The lifelong condition affects the brain and spinal cord, and results in nerves being destroyed....